Skip to main content
. 2021 May 29;10(11):2421. doi: 10.3390/jcm10112421

Table 3.

Preoperative visual acuity and postoperative visual outcome and endothelial cell loss in the DALK and PK groups.

DALK (mean ± SD)
n = 50
PK (mean ± SD)
n = 40
P
BCVA Preoperative 0.039 ± 0.037 0.038 ± 0.056 0.24
6 months 0.49 ± 0.17 0.48 ± 0.17 0.48
12 months 0.54 ± 0.17 0.52 ±0.14 0.41
logMAR Preoperative 1.41 ± 1.43 1.42 ± 1.25 0.24
6 months 0.31 ± 0.77 0.32 ± 0.77 0.48
12 months 0.27 ± 0.77 0.29 ± 0.85 0.42
Refractive astigmatism (D) 6 months 2.50 ± 1.41 2.01 ± 0.94 0.00196
12 months 2.48 ± 0.859 1.89 ± 0.86 0.00096
Endothelial cell loss cells/mm 2 (%) Preoperative 3035.56 ± 254.92
(100)
3091.80 ± 263.86
(100)
0.98
6 months 2920.82 ± 245.28
(3.78 ± 2.10)
2456.13 ± 209.61
(20.56 ± 10.11)
<0.0001
12 months 2808.20 ± 133.49
(7.49 ± 2.93)
1755.83 ± 149.85
(43.21 ± 13.04)
<0.0001
CCT (µm) Preoperative (419.64 ± 31.34) (369.60 ± 61.0) <0.0001
6 months 452.10 ± 89.14 528.87 ± 69.90 <0.0001
Astigmatism value 6 months 2.74 ± 1.42 2.02 ± 0.94 <0.002
12 months 2.49 ± 0.86 1.89 ± 0.86 <0.001

DALK, Deep Anterior Lamellar Keratoplasty; PK, Penetrating Keratoplasty; and CCT, Central Corneal Thickness.